WallStreetZenWallStreetZen

NASDAQ: CRDF
Cardiff Oncology Inc Stock Ownership - Who owns Cardiff Oncology?

Insider buying vs selling

Have Cardiff Oncology Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Gary W. PaceDirector2023-12-1930,000$1.37
$41.10kBuy
Gary W. PaceDirector2023-11-1022,950$0.98
$22.49kBuy

1 of 1

CRDF insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CRDF insiders and whales buy or sell their stock.

CRDF Shareholders

What type of owners hold Cardiff Oncology Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Robert Merrill Hunter11.32%5,065,004$13.17MInsider
Ra Capital Management LP7.36%3,290,000$8.55MInsider
Bridger Management LLC6.64%2,968,115$7.72MInsider
Vanguard Group Inc4.30%1,921,257$5.00MInstitution
Gary W. Pace2.56%1,145,522$2.98MInsider
Laurion Capital Management LP2.08%928,717$2.41MInstitution
Kira Sheinerman2.03%909,090$2.36MInsider
William J. Welch1.88%842,645$2.19MInsider
Gabriel Cerrone1.62%725,776$1.89MInsider
Millennium Management LLC1.53%683,299$1.78MInstitution

1 of 3

CRDF vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CRDF18.70%34.56%Net Buying
RLMD47.42%3.43%Net Buying
CTMX56.85%26.87%Net Buying
ADAG22.30%0.00%
KPTI63.52%31.97%Net SellingNet Selling

Cardiff Oncology Stock Ownership FAQ

Who owns Cardiff Oncology?

Cardiff Oncology (NASDAQ: CRDF) is owned by 18.70% institutional shareholders, 34.56% Cardiff Oncology insiders, and 46.74% retail investors. Robert Merrill Hunter is the largest individual Cardiff Oncology shareholder, owning 5.07M shares representing 11.32% of the company. Robert Merrill Hunter's Cardiff Oncology shares are currently valued at $12.87M.

If you're new to stock investing, here's how to buy Cardiff Oncology stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.